Skip to content

Clinical trials

Phase 3 Premature Birth trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Premature Birth Phase: Phase 3 Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20061
20072
20082
20091
20131
20161
20181
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
McMaster University2
University of British Columbia2
AMAG Pharmaceuticals, Inc.1
Children's & Women's Health Centre of British Columbia1
Dr. Elizabeth Asztalos1
GlaxoSmithKline1
Mount Sinai Hospital, Canada1
Nabeel Ali1
Ottawa Hospital Research Institute1
Sharp HealthCare1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Premature Birth14
Bronchopulmonary Dysplasia2
Pain2
Apnea1
Hemorrhage1
Hyaline Membrane Disease1
Hypotension1
Obstetric Labor Complications1
Obstetric Labor, Premature1
Pregnancy Complications1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.